Precision Medicine & Ion Channel Retreat 2019

17th Annual Ion Channel Retreat

Vancouver, British Columbia, Canada

July 24th– 26th, 2019


More information coming soon…


Precision Medicine Sessions

  1. Key Methodologies in Precision Medicine for Drug Discovery
  2. Next-Generation Sequencing – Applications and Advancement of Genomic Medicine
  3. Immunotherapies – Personalized Medicine and Human Cells
  4. Cancer Care, Diagnosis & Treatment
  5. Microarray and Microfluidic Technologies: Potential in Medicine & Diagnostics
  6. Latest Applications of Liquid Biopsy Research
  7. Emerging Role of Proteomics & the Microbiome into Precision Medicine
  8. Advances in the Forensic Space

Ion Channel Sessions

  1. Key Methodologies in Ion Channel Research for Drug Discovery
  2. CiPA and impact on drug discovery
  3. Role of Ion Channels in Cancer Treatment
  4. Ion Channels as Pain Targets
  5. Ion Channels as Disease Targets: Alzheimer and Neurodegenerative disease, ALS, Cystic Fibrosis, Epilepsy, Infectious diesease
  6. Cardiac Safety
  7. Emerging Areas of Ion Transporter Research
  8. Ion Channels & Immune System

Confirmed Speakers

  • Andrea Ghetti, Ph.D.- Chief Executive Officer at AnaBios
  • Christine Beeton, Ph.D.- Graduate Program Director of Biomedical Sciences and Associate Professor in the Department of Molecular Physiology and Biophysics at Baylor College of Medicine
  • Eric Nisenbaum, Ph.D.- Senior Director CNS Research at Alkermes
  • Fernanda Laezza, M.D., Ph.D.- Graduate Program Director and Associate Professor in the Department of Pharmacology and Toxicology at the University of Texas Medical Branch
  • Georg Terstappen, Ph.D.- Chief Scientific Officer at OxStem
  • James L. Ellis, Ph.D.- Chief Scientific Officer at Nocion Therapeutics
  • Marc Pourrier, Ph.D.- Vice President, Operations of IonsGate
  • Merritt Maduke, Ph.D.- Associate Professor of Molecular and Cellular Physiology at Stanford University
  • Michelina Iacovino, Ph.D.- Assistant Professor in the Department of Pediatrics, David Geffen School of Medicine at University of California Los Angeles
  • Owen McManus, Ph.D.- Chief Technology Officer at Q-State Biosciences

Past Attendees

  • Craig January, MD, PhD – Professor at the School of Medicine and Public Health, at the University of Wisconsin
  • William Catterall, PhD – Professor and Chair of University of Washington Department of Pharmacology
  • Arthur Brown, PhD – CEO of MemChan; former founder & CEO of ChanTest
  • Yuko Sekino, PhD – Director of Pharmacology National Institute of Health Sciences, Japan
  • Edward Stevens, PhD – Head of Electrophysiology at Pfizer, Cambridge, UK
  • Dennis Lo, MD, PhD – Associate Dean, Faculty of Medicine at CUHK, Foreign Associate US Academy of Sciences
  • George Chandy, MD, PhD – Professor at NTU SG and UC Irvine
  • Kurt Stoeckli President & CSO at Glenmark Pharmaceuticals, Switzerland
  • Hailin Zhang, MD, PhD – Vice President of Hebei Medical University
  • Richard Olsen, PhDDistinguished Professor of Neuroscience at the David Geffen School of Medicine at UCLA
  • Yuklam Lo Secretariat, and Honorary Chairman, Hong Kong Biotechlogy Organization
  • An Hailong Hebei University of Technology; Professor
  • Dan Minor, PhD – Professor, Biochemistry and Biophysics, Cellular and Molecular Pharmacology, University of California
  • Steve Goldstein, MD, PhDDirector at the Institute of Pediatric Sciences, University of Chicago
  • John Dunlop, PhD VP, Neuroscience Research at Amgen, Professor of Neuroscience, University of St Andrews
  • Laszlo Urban, MD, PhD – Executive Director at Novartis
  • Jean-Pierre Valentin, PhD – Senior Director, Head of Investigative Toxicology at UCB

Watch our short video of the last Vancouver-based PMICR event

Loading posts...